FDA approves ChoiceSpine for two new cervical spinal fusion devices — 3 insights

Knoxville, Tenn.-based spinal-device manufacturer, ChoiceSpine, has been granted FDA clearance to market two new devices, to be used together or separately in cervical spinal fusions.

Advertisement

The new technologies are the Tiger Shark C interbody device with BioBond technology and the Boomerang Anterior Cervical Plate.

Three insights:

1. Boomerang is a system of implants generated with a goal to simplify and enhance the efficiency of anterior cervical spinal fusions.

2. The device features a two-screw configuration and a single-step screw blocking tool for quick insertion and fixation of the anterior cervical spine.

3. Tiger Shark C is a 3D-manufactured titanium alloy cervical interbody device designed with BioBond technology, which is an organic, porous interbody architecture created for continuous porosity with an osteoconductive, hydrophilic surface.

ChoiceSpine is privately held by private equity firm Altus Capital Partners, which aims to make control investments exclusively in middle market manufacturing businesses.

More articles on devices:
Medtronic reaches 2nd ASC with newest Mazor edition — 3 highlights
FDA approves new spina bifida treatment that utilizes scopes
Innovasis HA PEEK Data Registry enrolls 150 patients

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.